Css LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Css LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $27.7 Million - $29.1 Million	190,903 Added 4772.58%	194,903 $29.5 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $101,347 - $177,961	1,219 Added 43.83%	4,000 $583,000
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $76,505 - $159,323	2,781 New	2,781 $95,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.56B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.